High materiality7/10
SpyGlass Pharma initiated with an Outperform at Raymond James
Why it may matterVerify against the original reporting
Outperform initiated; bullish setup.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
SGP received an analyst target update from Raymond James.
- Target: $39; Posted price: $25.17; Firm: Raymond James; Analyst: Christopher Raymond; Rating: Outperform
Key facts
- 01
Target: $39
- 02
Posted price: $25.17
- 03
Analyst firm: Raymond James
- 04
Analyst: Christopher Raymond
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.